Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$270K Sell
4,460
-22,728
-84% -$1.34M ﹤0.01% 973
2021
Q1
$1.47M Hold
27,188
0.02% 419
2020
Q4
$1.31M Sell
27,188
-516
-2% -$22.8K 0.02% 425
2020
Q3
$1.09M Hold
27,704
0.01% 427
2020
Q2
$889K Buy
27,704
+17,802
+180% +$619K 0.01% 758
2020
Q1
$336K Buy
9,902
+1,848
+23% +$74K 0.01% 939
2019
Q4
$386K Hold
8,054
﹤0.01% 1016
2019
Q3
$402K Sell
8,054
-1,430
-15% -$73K ﹤0.01% 1007
2019
Q2
$507K Sell
9,484
-3,885
-29% -$203K 0.01% 966
2019
Q1
$705K Sell
13,369
-44,292
-77% -$2.31M 0.01% 907
2018
Q4
$2.71M Sell
57,661
-1,480
-3% -$77.2K 0.03% 408
2018
Q3
$3.41M Sell
59,141
-36,000
-38% -$1.99M 0.03% 414
2018
Q2
$5.17M Hold
95,141
0.05% 275
2018
Q1
$4.5M Buy
+95,141
New +$4.77M 0.05% 298

Other funds holding NTR

QS Investors's NTR Position: Q2 2021 in Review

QS Investors reduced its Nutrien (NTR) stake by 84% in Q2 2021, selling an estimated $1.34M and leaving 4,460 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #973.

QS Investors first reported a position in NTR in Q1 2018 and has held it in 14 quarters since. The position peaked at $5.17M in Q2 2018. 573 funds tracked by Wall St. Rank hold NTR as of Q2 2021.

  • QS Investors held 4,460 shares of Nutrien worth $270K as of Q2 2021.
  • QS Investors sold 22,728 Nutrien shares in Q2 2021, an estimated $1.34M.
  • Nutrien made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #973 holding.
  • QS Investors first reported a position in Nutrien in Q1 2018 and has held it in 14 quarters since.
  • QS Investors's Nutrien position peaked at $5.17M in Q2 2018.
  • 573 funds tracked by Wall St. Rank held Nutrien as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.